Skip to content

Establishment of Regenerative Therapy for Intractable Wound

Establishment of Regenerative Therapy for Intractable Wound - Regenerative Therapy for Wound Healing

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023289
Enrollment
24
Registered
2016-07-25
Start date
2016-07-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable peripheral artery disease (arteriosclerosis obliterans and thronboangiitis obliterans) and intractable skin ulcer

Interventions

Platelet rich plasma(PRP) will be prepared from autologous peripheral blood sample. Autologous PRP 1.8ml will be impregnated with biodegradable gelatin microsphere (180mg). Prepared controlled relea

Sponsors

Department of Cardiovascular Medicine, Nippon Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Intractable ulcer due to any cause, which complicated with disability of daily life. Intractable by means out of indication or no response to conventional medical treatment at least 3 months.

Exclusion criteria

Exclusion criteria: Any infections by osteomyelitis or multiple resistant bacteria, which unable to control by antibiotics alone. Any malignant disease, which was treated within 5 years. Who need treatment (surgical approach) in addition to present treatment.

Design outcomes

Primary

MeasureTime frame
Efficacy determination by the changes of wound size and granulation recovery 4 weeks after treatment or termination period

Secondary

MeasureTime frame
Major adverse event and resting pain

Countries

Japan

Contacts

Public ContactGen Takagi

Nippon Medical School Department of Cardiovascular Medicine

gen52@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026